![]() |
市場調查報告書
商品編碼
2126637
眼科雷射市場:按雷射類型、應用程式、最終用戶和地區分類Ophthalmic Lasers Market, By Laser Type, By Application, By End User, By Geography |
||||||
預計到2026年,眼科雷射市場規模將達到20.1億美元,到2033年將達到29.8億美元。預計從2026年到2033年,該市場將以5.8%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年: | 2025 | 2026年市場規模: | 20.1億美元 |
| 歷史數據時期: | 2020年至2024年 | 預測期: | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率: | 5.80 | 2033年市場規模預測: | 29.8億美元 |
由於白內障、青光眼、糖尿病視網膜病變和屈光不正等眼科疾病的盛行率不斷上升,微創雷射眼科手術的普及,視力矯正手術需求的成長,以及眼科雷射技術的不斷進步,預計市場將穩步成長。
眼科雷射是一種先進的醫療設備,它利用聚焦雷射能量來診斷和治療各種眼科疾病,包括青光眼、白內障、視網膜疾病和屈光不正。這些系統能夠提高手術精確度、減少組織損傷、縮短恢復時間並改善患者預後,從而實現精準可控的手術操作。眼科雷射廣泛應用於醫院、眼科診所和門診手術中心,用於進行諸如LASIK、SMILE、雷射白內障手術、視網膜光凝固術和青光眼治療等手術。
全球對先進眼科醫療解決方案的需求日益成長,正顯著推動眼科雷射系統的應用。人口老化、視力障礙病例增加、醫療基礎設施改善以及人們對微創手術的偏好日益增強,都促使醫療專業人員採用先進的雷射技術。同時,人們對視力矯正手術的認知度提高以及獲得專業眼科醫療服務的途徑擴大,也推動了已開發經濟體和新興經濟體的市場成長。
技術進步和產品創新也在塑造眼科雷射市場的未來。製造商正致力於開發先進的飛秒雷射、準分子雷射、選擇性雷射小梁小梁網整型術(SLT)系統和影像導引雷射平台,以提高治療精度和工作流程效率。預計在預測期內,自動化雷射系統和先進手術技術的日益普及將為市場參與企業創造新的成長機會。
眼科雷射市場的發展受到以下因素的推動:眼科疾病的日益普遍、對微創眼科手術的需求不斷成長、基於雷射的視力矯正手術的日益普及、雷射系統的技術進步以及醫療基礎設施的擴張。
眼科市場成長的主要促進因素之一是全球眼科疾病負擔日益加重。白內障、青光眼、糖尿病視網膜病變、老齡化黃斑部病變(AMD)和屈光不正等病例的不斷增加,導致對先進眼科治療的需求顯著成長。根據世界衛生組織(WHO)統計,全球至少有22億人患有近視或遠視,其中白內障和未矯正的屈光不正最為常見。需要進行視力矯正和眼科疾病治療的患者人數不斷增加,推動了眼科雷射手術的需求成長。
另一個主要的成長要素是人們對微創眼科手術日益成長的偏好。雷射輔助手術因其諸多優勢,例如更高的手術精度、更少的不適感、更短的恢復時間和更好的臨床效果,正被越來越多的患者和醫療專業人員所接受。 LASIK、SMILE、飛秒雷射白內障手術和雷射青光眼治療等手術在全球日益普及,從而推動了對先進眼科雷射系統的需求。
人口老化進一步推動了市場擴張。白內障、青光眼和黃斑部病變等與老齡化相關的眼科疾病在老年族群中日益普遍,從而催生了對有效診斷和治療方案的需求。根據發表在《美國眼科雜誌》上的一項研究,預計全球40至80歲青光眼患者人數將從2020年的約7600萬增至2040年的1.118億,這將增加對青光眼治療(包括雷射治療)的需求。
持續的技術進步也在推動市場成長。製造商不斷推出先進的雷射平台,這些平台具有更高的精度、自動化程度和成像能力,從而改善治療效果。飛秒雷射、準分子雷射和雷射照射系統的技術創新正在拓展眼科雷射的應用範圍,包括屈光矯正手術、白內障治療和視網膜治療。
然而,眼科雷射市場面臨許多挑戰,例如眼科雷射設備和手術高成本、發展中地區缺乏先進的眼科醫療設施,以及能夠操作先進雷射系統的熟練眼科醫生短缺。這些因素可能會限制眼科雷射技術的普及,尤其是在對成本較為敏感的市場。儘管存在這些挑戰,但眼科醫療基礎設施投資的不斷增加以及對先進視力治療方案需求的成長,預計將為參與企業創造巨大的成長機會。
Ophthalmic Lasers Market is estimated to be valued at USD 2.01 Bn in 2026 and is expected to reach USD 2.98 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.01 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 2.98 Bn |
The market is projected to witness steady growth due to the rising prevalence of eye disorders such as cataracts, glaucoma, diabetic retinopathy, and refractive errors, increasing adoption of minimally invasive laser-based eye procedures, growing demand for vision correction surgeries, and continuous advancements in ophthalmic laser technologies.
Ophthalmic lasers are advanced medical devices that use focused laser energy for the diagnosis and treatment of various eye conditions, including glaucoma, cataracts, retinal disorders, and refractive errors. These systems enable precise and controlled procedures by improving surgical accuracy, reducing tissue damage, shortening recovery time, and enhancing patient outcomes. Ophthalmic lasers are widely used in hospitals, eye clinics, and ambulatory surgical centers for procedures such as LASIK, SMILE, laser cataract surgery, retinal photocoagulation, and glaucoma treatment.
Growing global demand for advanced eye care solutions is significantly increasing adoption of ophthalmic laser systems. Rising aging population, increasing cases of vision impairment, improving healthcare infrastructure, and growing preference for minimally invasive procedures are encouraging healthcare providers to adopt advanced laser technologies. At the same time, increasing awareness about vision correction procedures and expanding access to specialized eye care services are supporting market growth across developed and emerging economies.
Technological advancements and product innovation are also shaping the future of the ophthalmic lasers market. Manufacturers are focusing on developing advanced femtosecond lasers, excimer lasers, selective laser trabeculoplasty (SLT) systems, and imaging-guided laser platforms to improve treatment precision and workflow efficiency. Growing adoption of automated laser systems and advanced surgical technologies is expected to create new growth opportunities for market participants during the forecast period.
The ophthalmic lasers market is driven by the rising prevalence of eye disorders, increasing demand for minimally invasive ophthalmic procedures, growing adoption of laser-based vision correction surgeries, technological advancements in laser systems, and expanding healthcare infrastructure.
One of the primary factors driving market growth is the increasing global burden of eye diseases. Rising cases of cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive errors are creating significant demand for advanced ophthalmic treatments. According to the World Health Organization (WHO), at least 2.2 Bn people globally have near or distance vision impairment, with cataracts and uncorrected refractive errors among the leading causes. The growing number of patients requiring vision correction and eye disease treatment is increasing demand for ophthalmic laser procedures.
Another major growth driver is the increasing preference for minimally invasive eye surgeries. Patients and healthcare providers are increasingly adopting laser-based procedures due to benefits such as improved surgical precision, reduced discomfort, shorter recovery periods, and better clinical outcomes. Procedures such as LASIK, SMILE, femtosecond laser-assisted cataract surgery, and laser glaucoma treatments are gaining popularity worldwide, supporting demand for advanced ophthalmic laser systems.
The growing aging population is further contributing to market expansion. Age-related eye disorders such as cataracts, glaucoma, and macular degeneration are becoming increasingly common among elderly populations, creating demand for effective diagnostic and treatment solutions. According to research published in the American Journal of Ophthalmology, the number of people aged 40-80 years living with glaucoma worldwide is projected to increase from approximately 76 million in 2020 to 111.8 million by 2040, increasing the need for glaucoma management procedures including laser treatments.
Continuous technological advancements are also supporting market growth. Manufacturers are introducing advanced laser platforms with improved precision, automation, imaging capabilities, and enhanced treatment outcomes. Innovations in femtosecond lasers, excimer lasers, and laser delivery systems are expanding the application of ophthalmic lasers across refractive surgery, cataract management, and retinal treatments.
However, the market faces challenges such as high costs associated with ophthalmic laser equipment and procedures, limited availability of advanced eye care facilities in developing regions, and the need for skilled ophthalmic surgeons to operate advanced laser systems. These factors may restrict adoption, particularly in cost-sensitive markets. Despite these challenges, increasing investment in eye care infrastructure and rising demand for advanced vision treatment solutions are expected to create significant growth opportunities for market participants.